Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Novan Inc | NOVN | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.0941 | 0.0941 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 0.082 - 1.3786 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | US$ 0.0941 | USD |
Novan Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
US$ 2.64M | - | - | - | -18.68 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Novan News
Date | Time | Source | News Article |
---|---|---|---|
5/01/2024 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
5/01/2024 | 10:49 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration.. |
1/05/2024 | 08:23 | GlobeNewswire Inc. | Novartis expands production of Pluvicto™ with addition of.. |
12/10/2023 | 18:30 | GlobeNewswire Inc. | Novartis presents new 48-week results from Phase III.. |
12/08/2023 | 08:15 | GlobeNewswire Inc. | Latest Novartis Kisqali® NATALEE analysis reinforces 25%.. |
12/05/2023 | 18:16 | GlobeNewswire Inc. | Novartis receives FDA approval for Fabhalta® (iptacopan),.. |
11/20/2023 | 00:15 | GlobeNewswire Inc. | Novartis showcases significant data updates from Kisqali®,.. |
10/24/2023 | 16:01 | Edgar (US Regulatory) | Form 8-K - Current report |
10/20/2023 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
9/07/2023 | 15:58 | Edgar (US Regulatory) | Form 8-K - Current report |
8/24/2023 | 15:31 | Edgar (US Regulatory) | Form 8-K - Current report |
7/26/2023 | 15:50 | Edgar (US Regulatory) | Form 8-K - Current report |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NOVN Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 1.14 | 1.3786 | 0.082 | 0.2985157 | 1,335,780 | -1.05 | -91.75% |
3 Years | 1.18 | 20.74 | 0.082 | 7.91 | 897,242 | -1.09 | -92.03% |
5 Years | 1.20 | 20.74 | 0.082 | 1.52 | 4,942,728 | -1.11 | -92.16% |
Novan Description
Novan Inc is a clinical-stage biotechnology company. It is engaged in developing therapies based on nitric oxide for treating dermatology and oncovirus related diseases. |